XT
MRNA icon

XTX Topco’s Moderna MRNA Stock Holding History

XTX Topco’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
+43,658
New +$2.04M 0.04% 748
2025
Q4 		– Sell
-36,755
Closed -$949K – 3621
2025
Q3 		$949K Buy
+36,755
New +$1.03M 0.05% 612
2025
Q2 		– Sell
-32,049
Closed -$909K – 2879
2025
Q1 		$909K Buy
32,049
+27,237
+566% +$967K 0.05% 622
2024
Q4 		$200K Sell
4,812
-23,444
-83% -$1.12M 0.02% 1558
2024
Q3 		$1.89M Buy
28,256
+25,400
+889% +$2.33M 0.14% 160
2024
Q2 		$339K Sell
2,856
-13,243
-82% -$1.68M 0.03% 881
2024
Q1 		$1.72M Buy
+16,099
New +$1.62M 0.23% 46
2023
Q3 		– Sell
-2,050
Closed -$249K – 1839
2023
Q2 		$249K Buy
+2,050
New +$273K 0.04% 853
2023
Q1 		– Sell
-4,327
Closed -$777K – 1524
2022
Q4 		$777K Buy
+4,327
New +$708K 0.16% 141
2022
Q3 		– Sell
-3,466
Closed -$495K – 1282
2022
Q2 		$495K Sell
3,466
-722
-17% -$103K 0.2% 116
2022
Q1 		$721K Sell
4,188
-971
-19% -$163K 0.32% 72
2021
Q4 		$1.31M Sell
5,159
-1,074
-17% -$314K 0.74% 6
2021
Q3 		$2.4M Buy
6,233
+5,299
+567% +$1.95M 0.81% 7
2021
Q2 		$219K Buy
+934
New +$167K 0.07% 522

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's MRNA Position: Q1 2026 in Review

XTX Topco opened a new position in Moderna (MRNA) in Q1 2026: 43,658 shares worth $2.22M. The stake represents 0.04% of the portfolio and ranks #748 among its holdings. This is a return to the name: XTX Topco previously reported a position in MRNA as recently as Q3 2025.

XTX Topco first reported a position in MRNA in Q2 2021 and has held it in 14 quarters since. The position peaked at $2.4M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • XTX Topco held 43,658 shares of Moderna worth $2.22M as of Q1 2026.
  • Moderna was a new XTX Topco position in Q1 2026.
  • Moderna made up 0.04% of XTX Topco's portfolio in Q1 2026, its #748 holding.
  • XTX Topco first reported a position in Moderna in Q2 2021 and has held it in 14 quarters since.
  • XTX Topco's Moderna position peaked at $2.4M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.